BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Richardson JD, Nelson AJ, Zannettino AC, Gronthos S, Worthley SG, Psaltis PJ. Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Rev Rep 2013;9:281-302. [PMID: 22529015 DOI: 10.1007/s12015-012-9366-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Labedz-Maslowska A, Szkaradek A, Mierzwinski T, Madeja Z, Zuba-Surma E. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans. Cells 2021;10:1908. [PMID: 34440677 DOI: 10.3390/cells10081908] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Souza Vieira S, Antonio EL, de Melo BL, Neves Dos Santos LF, Santana ET, Feliciano R, Marques FLN, de Paula Faria D, Buchpiguel CA, Silva JA Jr, Tucci PJF, Serra AJ. Increased Myocardial Retention of Mesenchymal Stem Cells Post-MI by Pre-Conditioning Exercise Training. Stem Cell Rev Rep 2020;16:730-41. [PMID: 32306279 DOI: 10.1007/s12015-020-09970-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Blocki A, Beyer S, Jung F, Raghunath M. The controversial origin of pericytes during angiogenesis - Implications for cell-based therapeutic angiogenesis and cell-based therapies. Clin Hemorheol Microcirc 2018;69:215-32. [PMID: 29758937 DOI: 10.3233/CH-189132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
4 Nguyen DC, Lewis HC, Joyner C, Warren V, Xiao H, Kissick HT, Wu R, Galipeau J, Lee FE. Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells. J Extracell Vesicles 2018;7:1463778. [PMID: 29713426 DOI: 10.1080/20013078.2018.1463778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
5 Zhang J, Yun S, Bi J, Dai S, Du Y, Zannettino ACW, Zhang H. Enhanced multi-lineage differentiation of human mesenchymal stem/stromal cells within poly(N-isopropylacrylamide-acrylic acid) microgel-formed three-dimensional constructs. J Mater Chem B 2018;6:1799-814. [PMID: 32254252 DOI: 10.1039/c8tb00376a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang Q, Hwang JW, Oh J, Park CH, Chung SH, Lee Y, Baek J, Ryoo H, Woo KM. Effects of the fibrous topography-mediated macrophage phenotype transition on the recruitment of mesenchymal stem cells: An in vivo study. Biomaterials 2017;149:77-87. [DOI: 10.1016/j.biomaterials.2017.10.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
7 Psaltis PJ, Schwarz N, Toledo-Flores D, Nicholls SJ. Cellular Therapy for Heart Failure. Curr Cardiol Rev 2016;12:195-215. [PMID: 27280304 DOI: 10.2174/1573403x12666160606121858] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
8 Blocki A, Löwenberg C, Jiang Y, Kratz K, Neffe AT, Jung F, Lendlein A. Response of encapsulated cells to a gelatin matrix with varied bulk and microenvironmental elastic properties: Response of Encapsulated Cells to Various Gelatin Matrices. Polym Adv Technol 2017;28:1245-51. [DOI: 10.1002/pat.3947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Iwanski J, Wong RK, Larson DF, Ferng AS, Runyan RB, Goldstein S, Khalpey Z. Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy. Springerplus 2016;5:738. [PMID: 27376006 DOI: 10.1186/s40064-016-2355-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 De Becker A, Van Riet I. Mesenchymal Stromal Cell Therapy in Hematology: From Laboratory to Clinic and Back Again. Stem Cells Dev. 2015;24:1713-1729. [PMID: 25923433 DOI: 10.1089/scd.2014.0564] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
11 Psaltis PJ, Spoon DB, Wong DT, Gulati R. An update on stem cell therapies for acute coronary syndrome. Curr Cardiol Rep 2014;16:526. [PMID: 25073868 DOI: 10.1007/s11886-014-0526-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Chen J, Liu Z, Hong MM, Zhang H, Chen C, Xiao M, Wang J, Yao F, Ba M, Liu J, Guo ZK, Zhong J. Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells. PLoS One 2014;9:e115316. [PMID: 25514634 DOI: 10.1371/journal.pone.0115316] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
13 Skiles ML, Hanna B, Rucker L, Tipton A, Brougham-Cook A, Jabbarzadeh E, Blanchette JO. ASC spheroid geometry and culture oxygenation differentially impact induction of preangiogenic behaviors in endothelial cells. Cell Transplant 2015;24:2323-35. [PMID: 25197983 DOI: 10.3727/096368914X684051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
14 Chinnadurai R, Garcia MA, Sakurai Y, Lam WA, Kirk AD, Galipeau J, Copland IB. Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo. Stem Cell Reports. 2014;3:60-72. [PMID: 25068122 DOI: 10.1016/j.stemcr.2014.05.003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 9.9] [Reference Citation Analysis]
15 Turksen K. Adult stem cells and cardiac regeneration. Stem Cell Rev Rep 2013;9:537-40. [PMID: 23775698 DOI: 10.1007/s12015-013-9448-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
16 Richardson JD, Psaltis PJ, Frost L, Paton S, Carbone A, Bertaso AG, Nelson AJ, Wong DT, Worthley MI, Gronthos S, Zannettino AC, Worthley SG. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction. Cytotherapy 2014;16:460-70. [DOI: 10.1016/j.jcyt.2013.07.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
17 Ilmer M, Vykoukal J, Boiles AR, Coleman M, Alt E. Two sides of the same coin: stem cells in cancer and regenerative medicine. FASEB j 2014;28:2748-61. [DOI: 10.1096/fj.13-244640] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
18 Bain O, Detela G, Kim H, Mason C, Mathur A, Wall IB. Altered hMSC functional characteristics in short-term culture and when placed in low oxygen environments: implications for cell retention at physiologic sites. Regenerative Medicine 2014;9:153-65. [DOI: 10.2217/rme.13.91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013;45:e54. [PMID: 24232253 DOI: 10.1038/emm.2013.94] [Cited by in Crossref: 688] [Cited by in F6Publishing: 691] [Article Influence: 76.4] [Reference Citation Analysis]
20 Richardson JD, Bertaso AG, Psaltis PJ, Frost L, Carbone A, Paton S, Nelson AJ, Wong DT, Worthley MI, Gronthos S, Zannettino AC, Worthley SG. Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. J Card Fail 2013;19:342-53. [PMID: 23663817 DOI: 10.1016/j.cardfail.2013.03.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
21 Psaltis PJ, Peterson KM, Xu R, Franchi F, Witt T, Chen IY, Lerman A, Simari RD, Gambhir SS, Rodriguez-Porcel M. Noninvasive monitoring of oxidative stress in transplanted mesenchymal stromal cells. JACC Cardiovasc Imaging. 2013;6:795-802. [PMID: 23643284 DOI: 10.1016/j.jcmg.2012.11.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
22 Raynaud CM, Halabi N, Elliott DA, Pasquier J, Elefanty AG, Stanley EG, Rafii A. Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS One 2013;8:e54524. [PMID: 23342164 DOI: 10.1371/journal.pone.0054524] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
23 Martin I, Baldomero H, Bocelli-tyndall C, Passweg J, Saris D, Tyndall A. The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010. Tissue Engineering Part A 2012;18:2268-79. [DOI: 10.1089/ten.tea.2012.0169] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
24 Sassoli C, Zecchi-Orlandini S, Formigli L. Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration. Cells 2012;1:832-50. [PMID: 24710532 DOI: 10.3390/cells1040832] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
25 Díez Villanueva P, Sanz-Ruiz R, Núñez García A, Fernández Santos ME, Sánchez PL, Fernández-Avilés F. Functional multipotency of stem cells: what do we need from them in the heart? Stem Cells Int 2012;2012:817364. [PMID: 22966237 DOI: 10.1155/2012/817364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]